42.5
Inhibikase Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
24.4
FY23:
14.2
FY24:
98.5
FY25:
180
(positive)
millions USD
FY21:
0
FY22:
0.57
FY23:
0.30
FY24:
0.15
FY25:
1.10
Total assets
Change from FY21 to FY25
millions USD
FY21:
42.5
FY22:
24.9
FY23:
14.5
FY24:
98.6
FY25:
181
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.05
FY22:
3.70
FY23:
3.44
FY24:
3.73
FY25:
8.30
(negative)
millions USD
FY21:
0
FY22:
0.21
FY23:
0.09
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
38.4
FY22:
21.0
FY23:
11.0
FY24:
94.9
FY25:
173
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
42.5
FY22:
24.9
FY23:
14.5
FY24:
98.6
FY25:
181
All amounts in millions USD